ArticleScientific reports2025
High prevalence of vector-borne protozoa and bacteria in dogs from Chad determined using a targeted next-generation sequencing approach.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data on vector-borne pathogens infecting dogs from sub-Saharan Africa is limited. In this study, we assessed the prevalence of VBPs, their associated risk factors, and pathogen interactions in domestic dogs. Whole blood samples were obtained for 1202 apparently healthy dogs in Chad from September to October 2021, and nucleic acids were extracted and then subjected to a targeted next-generation sequencing (tNGS) assay for detection of 15 VBPs. Overall, 88.7% of the dogs were positive for at least one pathogen, and 62.9% were coinfected with two or more VBPs. The most frequent pathogen detected was Hepatozoon canis in 62.4% of the dogs, Mycoplasma haemocanis in 59.2%, Anaplasma platys in 29.2%, Candidatus Mycoplasma haematoparvum in 21.2%, Ehrlichia canis in 20.3%, Babesia vogeli in 2.0% and Candidatus Mycoplasma turicensis in 1.5%. While most of the dogs (62.9%) were co-infected with two or more VBPs, having an infection with three pathogens (30.8%) was more common. According to multivariable logistic regression analysis, being a senior dog and residing in Chari Baguirmi south were identified as potential risk factors for infection by most of the pathogens. Network analyses revealed complex interactions suggesting facilitative associations among VBPs. These results are useful in expanding the knowledge of VBPs in Africa and establishing a baseline for downstream studies into hemotropic mycoplasmas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.